Filippatos, G., Khan, S.S., Ambrosy, A.P., Cleland, J.G.F., Collins, S.P., Lam, C.S.P., Angermann, C.E., Gheorghiade, M., International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry (2015) Eur J Heart Fail, 17, pp. 527-533
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) (1987) N Engl J Med, 316, pp. 1429-1435
McMurray, J.J.J.V., Improving outcomes in heart failure: a personal perspective (2015) Eur Heart J, 36, pp. 3467-3470
Wang, T.J., Natural history of asymptomatic left ventricular systolic dysfunction in the community (2003) Circulation, 108, pp. 977-982
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions (1992) N Engl J Med, 327, pp. 685-691
Butler, J., Fonarow, G.C., Zile, M.R., Lam, C.S., Roessig, L., Schelbert, E.B., Shah, S.J., Gheorghiade, M., Developing therapies for heart failure with preserved ejection fraction: current state and future directions (2014) JACC Heart Fail, 2, pp. 97-112
McMurray, J.J.V., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Zeiher, A., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart (2012) Eur J Heart Fail, 14, pp. 803-869
McMurray, J.J.V., Clinical practice. Systolic heart failure (2010) N Engl J Med, 3623, pp. 228-238
Chen, J., Normand, S.-L.T., Wang, Y., Krumholz, H.M., National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008 (2011) JAMA, 306, pp. 1669-1678
Dunlay, S.M., Redfield, M.M., Weston, S.A., Therneau, T.M., Hall Long, K., Shah, N.D., Roger, V.L., Hospitalizations after heart failure diagnosis a community perspective (2009) J Am Coll Cardiol, 54, pp. 1695-1702
Metra, M., Ponikowski, P., Dickstein, K., McMurray, J.J.V., Gavazzi, A., Bergh, C.-H., Fraser, A.G., Komajda, M., Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, 9, pp. 684-694
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Drazner, M.H., Fonarow, G.C., Wilkoff, B.L., 2013 ACCF/AHA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) Circulation, 128, pp. 1810-1852
Killip, T., Kimball, J.T., Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients (1967) Am J Cardiol, 20, pp. 457-464
Mosterd, A., Hoes, A.W., Clinical epidemiology of heart failure (2007) Heart, 93, pp. 1137-1146
Redfield, M.M., Jacobsen, S.J., Burnett, J.C., Mahoney, D.W., Bailey, K.R., Rodeheffer, R.J., Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic (2003) JAMA, 289, pp. 194-202
Bleumink, G.S., Knetsch, A.M., Sturkenboom, M.C.J.M., Straus, S.M.J.M., Hofman, A., Deckers, J.W., Witteman, J.C.M., Stricker, B.H.C., Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study (2004) Eur Heart J England, 25, pp. 1614-1619
Ceia, F., Fonseca, C., Mota, T., Morais, H., Matias, F., De Sousa, A., Oliveira, A.G., Prevalence of chronic heart failure in Southwestern Europe: the EPICA study (2002) Eur J Heart Fail, 4, pp. 531-539
van Riet, E.E.S., Hoes, A.W., Limburg, A., Landman, M.A.J., van der Hoeven, H., Rutten, F.H., Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion (2014) Eur J Heart Fail, 16, pp. 772-777
Filippatos, G., Parissis, J.T., Heart failure diagnosis and prognosis in the elderly: the proof of the pudding is in the eating (2011) Eur J Heart Fail, 13, pp. 467-471
Boonman-de Winter, L.J.M., Rutten, F.H., Cramer, M.J.M., Landman, M.J., Liem, A.H., Rutten, G.E.H.M., Hoes, A.W., High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes (2012) Diabetologia, 55, pp. 2154-2162
van Riet, E.E.S., Hoes, A.W., Wagenaar, K.P., Limburg, A., Landman, M.A.J., Rutten, F.H., Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review (2016) Eur J Heart Fail
Abhayaratna, W.P., Smith, W.T., Becker, N.G., Marwick, T.H., Jeffery, I.M., McGill, D.A., Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study (2006) Med J Aust, 184, pp. 151-154
Tiller, D., Russ, M., Greiser, K.H., Nuding, S., Ebelt, H., Kluttig, A., Kors, J.A., Werdan, K., Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population—the CARLA study (2013) PLoS One, 8
Mureddu, G.F., Agabiti, N., Rizzello, V., Forastiere, F., Latini, R., Cesaroni, G., Masson, S., Boccanelli, A., Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy (2012) Eur J Heart Fail, 14, pp. 718-729
Badano, L.P., Albanese, M.C., De Biaggio, P., Rozbowsky, P., Miani, D., Fresco, C., Fioretti, P.M., Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction (2004) J Am Soc Echocardiogr, 17, pp. 253-261
Philbin, E.F., Rocco, T.A., Lindenmuth, N.W., Ulrich, K., Jenkins, P.L., Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors (2000) Am J Med, 109, pp. 605-613
Magaña-Serrano, J.A., Almahmeed, W., Gomez, E., Al-Shamiri, M., Adgar, D., Sosner, P., Herpin, D., Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study (2011) Am J Cardiol, 108, pp. 1289-1296
Peyster, E., Norman, J., Domanski, M., Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly population (2004) J Card Fail, 10, pp. 49-54
Hellermann, J.P., Jacobsen, S.J., Reeder, G.S., Lopez-Jimenez, F., Weston, S.A., Roger, V.L., Heart failure after myocardial infarction: prevalence of preserved left ventricular systolic function in the community (2003) Am Heart J, 145, pp. 742-748
Gerber, Y., Weston, S.A., Redfield, M.M., Chamberlain, A.M., Manemann, S.M., Jiang, R., Killian, J.M., Roger, V.L., A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010 (2015) JAMA Intern Med, 175, pp. 996-1004
Owan, T.E., Hodge, D.O., Herges, R.M., Jacobsen, S.J., Roger, V.L., Redfield, M.M., Trends in prevalence and outcome of heart failure with preserved ejection fraction (2006) N Engl J Med, 355, pp. 251-259
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis (2012) Eur Heart J, 33, pp. 1750-1757
Lam, C.S.P., Solomon, S.D., The middle child in heart failure: heart failure with mid-range ejection fraction (40–50%) (2014) Eur J Heart Fail, 16, pp. 1049-1055
Maggioni, A.P., Dahlström, U., Filippatos, G., Chioncel, O., Leiro, M.C., Drozdz, J., Fruhwald, F., Tavazzi, L., EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) (2013) Eur J Heart Fail, 15, pp. 808-817
Pocock, S.J., Ariti, C.A., McMurray, J.J.V., Maggioni, A., Køber, L., Squire, I.B., Swedberg, K., Doughty, R.N., Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies (2013) Eur Heart J, 34, pp. 1404-1413
Rahimi, K., Bennett, D., Conrad, N., Williams, T.M., Basu, J., Dwight, J., Woodward, M., MacMahon, S., Risk prediction in patients with heart failure (2014) JACC Heart Fail, 2, pp. 440-446
Ouwerkerk, W., Voors, A.A., Zwinderman, A.H., Factors influencing the predictive power of models for predicting mortality and/or heart-failure hospitalization in patients with heart failure (2014) JACC Heart Fail, 2, pp. 429-436
Lupón, J., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Zamora, E., Urrutia, A., Bayes-Genis, A., Development of a novel heart failure risk tool: the Barcelona bio-heart failure risk calculator (BCN bio-HF calculator) (2014) PLoS One, 9
Levy, W.C., The Seattle Heart Failure Model: prediction of survival in heart failure (2006) Circulation, 113, pp. 1424-1433
Mozaffarian, D., Anker, S.D., Anand, I., Linker, D.T., Sullivan, M.D., Cleland, J.G.F., Carson, P.E., Levy, W.C., Prediction of mode of death in heart failure: the Seattle Heart Failure Model (2007) Circulation, 116, pp. 392-398
Davie, P., Francis, C.M., Caruana, L., Sutherland, G.R., McMurray, J.J., Assessing diagnosis in heart failure: which features are any use (1997) QJM, 90, pp. 335-339
Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M.R., Glasziou, P., Mant, D., Hobbs, F.D.R., Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care (2009) Health Technol Assess, 13, pp. 1–207, iii
Oudejans, I., Mosterd, A., Bloemen, J.A., Valk, M.J., Van Velzen, E., Wielders, J.P., Zuithoff, N.P., Hoes, A.W., Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests (2011) Eur J Heart Fail, 13, pp. 518-527
Fonseca, C., Diagnosis of heart failure in primary care (2006) Heart Fail Rev, 11, pp. 95-107
Kelder, J.C., Cramer, M.J., van Wijngaarden, J., van Tooren, R., Mosterd, A., Moons, K.G.M., Lammers, J.W., Hoes, A.W., The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure (2011) Circulation, 124, pp. 2865-2873
Boonman-de Winter, L.J.M., Rutten, F.H., Cramer, M.J., Landman, M.J., Zuithoff, N.P.A., Liem, A.H., Hoes, A.W., Efficiently screening heart failure in patients with type 2 diabetes (2015) Eur J Heart Fail, 17, pp. 187-195
Rutten, F.H., Moons, K.G.M., Cramer, M.-J.M., Grobbee, D.E., Zuithoff, N.P.A., Lammers, J.-W.J., Hoes, A.W., Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study (2005) BMJ, 331, p. 1379
Daniels, L.B., Clopton, P., Bhalla, V., Krishnaswamy, P., Nowak, R.M., McCord, J., Hollander, J.E., Maisel, A.S., How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study (2006) Am Heart J, 151, pp. 999-1005
Wong, C.M., Hawkins, N.M., Jhund, P.S., MacDonald, M.R., Solomon, S.D., Granger, C.B., Yusuf, S., McMurray, J.J.V., Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) (2013) J Am Coll Cardiol, 62, pp. 1845-1854
Wong, C.M., Hawkins, N.M., Petrie, M.C., Jhund, P.S., Gardner, R.S., Ariti, C.A., Poppe, K.K., McMurray, J.J.V., Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) (2014) Eur Heart J, 35, pp. 2714-2721
Thibodeau, J.T., Turer, A.T., Gualano, S.K., Ayers, C.R., Velez-Martinez, M., Mishkin, J.D., Patel, P.C., Drazner, M.H., Characterization of a novel symptom of advanced heart failure: bendopnea (2014) JACC Heart Fail, 2, pp. 24-31
Roberts, E., Ludman, A.J., Dworzynski, K., Al-Mohammad, A., Cowie, M.R., McMurray, J.J.V., Mant, J., The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting (2015) BMJ, 350, p. h910
Maisel, A., Mueller, C., Adams, K., Anker, S.D., Aspromonte, N., Cleland, J.G.F., Cohen-Solal, A., Braunwald, E., State of the art: using natriuretic peptide levels in clinical practice (2008) Eur J Heart Fail, 10, pp. 824-839
Zaphiriou, A., Robb, S., Murray-Thomas, T., Mendez, G., Fox, K., McDonagh, T., Hardman, S.M.C., Cowie, M.R., The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study (2005) Eur J Heart Fail, 7, pp. 537-541
Fuat, A., Murphy, J.J., Hungin, A.P.S., Curry, J., Mehrzad, A.A., Hetherington, A., Johnston, J.I., Cawley, P., The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure (2006) Br J Gen Pract, 56, pp. 327-333
Yamamoto, K., Burnett, J.C., Bermudez, E.A., Jougasaki, M., Bailey, K.R., Redfield, M.M., Clinical criteria and biochemical markers for the detection of systolic dysfunction (2000) J Card Fail, 6, pp. 194-200
Cowie, M.R., Struthers, A.D., Wood, D.A., Coats, A.J., Thompson, S.G., Poole-Wilson, P.A., Sutton, G.C., Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care (1997) Lancet, 350, pp. 1349-1353
Krishnaswamy, P., Lubien, E., Clopton, P., Koon, J., Kazanegra, R., Wanner, E., Gardetto, N., Maisel, A.S., Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction (2001) Am J Med, 111, pp. 274-279
Kelder, J.C., Cramer, M.J., Verweij, W.M., Grobbee, D.E., Hoes, A.W., Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure (2011) J Card Fail, 17, pp. 729-734
Madamanchi, C., Alhosaini, H., Sumida, A., Runge, M.S., Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure (2014) Int J Cardiol, 176, pp. 611-617
Davie, A.P., Francis, C.M., Love, M.P., Caruana, L., Starkey, I.R., Shaw, T.R., Sutherland, G.R., McMurray, J.J., Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction (1996) BMJ, 312, p. 222
Thomas, J.T., Kelly, R.F., Thomas, S.J., Stamos, T.D., Albasha, K., Parrillo, J.E., Calvin, J.E., Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure (2002) Am J Med, 112, pp. 437-445
Paulus, W.J., Tschope, C., Sanderson, J.E., Rusconi, C., Flachskampf, F.A., Rademakers, F.E., Marino, P., Brutsaert, D.L., How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology (2007) Eur Heart J, 28, pp. 2539-2550
Marwick, T.H., Raman, S.V., Carrió, I., Bax, J.J., Recent developments in heart failure imaging (2010) JACC Cardiovasc Imaging, 3, pp. 429-439
Dokainish, H., Nguyen, J.S., Bobek, J., Goswami, R., Lakkis, N.M., Assessment of the American Society of Echocardiography-European Association of Echocardiography guidelines for diastolic function in patients with depressed ejection fraction: an echocardiographic and invasive haemodynamic study (2011) Eur J Echocardiogr, 12, pp. 857-864
Kirkpatrick, J.N., Vannan, M.A., Narula, J., Lang, R.M., Echocardiography in heart failure: applications, utility, and new horizons (2007) J Am Coll Cardiol, 50, pp. 381-396
Nagueh, S.F., Bhatt, R., Vivo, R.P., Krim, S.R., Sarvari, S.I., Russell, K., Edvardsen, T., Estep, J.D., Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure (2011) Circ Cardiovasc Imaging, 4, pp. 220-227
Caballero, L., Kou, S., Dulgheru, R., Gonjilashvili, N., Athanassopoulos, G.D., Barone, D., Baroni, M., Lancellotti, P., Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study (2015) Eur Heart J Cardiovasc Imaging, 16, pp. 1031-1041
Garbi, M., McDonagh, T., Cosyns, B., Bucciarelli-Ducci, C., Edvardsen, T., Kitsiou, A., Nieman, K., Lancellotti, P., Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature review (2015) Eur Heart J Cardiovasc Imaging, 16, pp. 147-153
Lang, R.M., Badano, L.P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F.A., Voigt, J.-U., Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging (2015) Eur Heart J Cardiovasc Imaging, 16, pp. 233-270
Gimelli, A., Lancellotti, P., Badano, L.P., Lombardi, M., Gerber, B., Plein, S., Neglia, D., Perrone-Filardi, P., Non-invasive cardiac imaging evaluation of patients with chronic systolic heart failure: a report from the European Association of Cardiovascular Imaging (EACVI) (2014) Eur Heart J, 35, pp. 3417-3425
Voigt, J.-U., Pedrizzetti, G., Lysyansky, P., Marwick, T.H., Houle, H., Baumann, R., Pedri, S., Badano, L.P., Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging (2015) Eur Heart J Cardiovasc Imaging, 16, pp. 1-11
Ewald, B., Ewald, D., Thakkinstian, A., Attia, J., Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction (2008) Intern Med J, 38, pp. 101-113
Doust, J.A., Glasziou, P.P., Pietrzak, E., Dobson, A.J., A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure (2004) Arch Intern Med, 164, pp. 1978-1984
Gustafsson, F., Steensgaard-Hansen, F., Badskjaer, J., Poulsen, A.H., Corell, P., Hildebrandt, P., Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure (2005) J Card Fail, 11, pp. S15-S20
Nielsen, O.W., Rasmussen, V., Christensen, N.J., Hansen, J.F., Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability (2004) Scand J Clin Lab Invest, 64, pp. 619-628
Kelly, J.P., Mentz, R.J., Mebazaa, A., Voors, A.A., Butler, J., Roessig, L., Fiuzat, M., Lam, C.S.P., Patient selection in heart failure with preserved ejection fraction clinical trials (2015) J Am Coll Cardiol, 65, pp. 1668-1682
Cohen, G.I., Pietrolungo, J.F., Thomas, J.D., Klein, A.L., A practical guide to assessment of ventricular diastolic function using Doppler echocardiography (1996) J Am Coll Cardiol, 27, pp. 1753-1760
Gilman, G., Nelson, T.A., Hansen, W.H., Khandheria, B.K., Ommen, S.R., Diastolic function: a sonographer's approach to the essential echocardiographic measurements of left ventricular diastolic function (2007) J Am Soc Echocardiogr, 20, pp. 199-209
Nagueh, S.F., Appleton, C.P., Gillebert, T.C., Marino, P.N., Oh, J.K., Smiseth, O.A., Waggoner, A.D., Evangelisa, A., Recommendations for the evaluation of left ventricular diastolic function by echocardiography (2009) Eur J Echocardiogr, 10, pp. 165-193
Nishimura, R.A., Appleton, C.P., Redfield, M.M., Ilstrup, D.M., Holmes, D.R., Tajik, A.J., Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study (1996) J Am Coll Cardiol, 28, pp. 1226-1233
Ommen, S.R., Nishimura, R.A., Appleton, C.P., Miller, F.A., Oh, J.K., Redfield, M.M., Tajik, A.J., Clinical utility of Doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study (2000) Circulation, 102, pp. 1788-1794
Erdei, T., Smiseth, O.A., Marino, P., Fraser, A.G., A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group (2014) Eur J Heart Fail, 16, pp. 1345-1361
Donal, E., Lund, L.H., Oger, E., Reynaud, A., Schnell, F., Persson, H., Drouet, E., Daubert, C., Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study (2016) Eur Heart J Cardiovasc Imaging, 17, pp. 106-113
Borlaug, B.A., Nishimura, R.A., Sorajja, P., Lam, C.S.P., Redfield, M.M., Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction (2010) Circ Heart Fail, 3, pp. 588-595
Elliott, P.M., Anastasakis, A., Borger, M.A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A.A., Watkins, H., 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) (2014) Eur Heart J, 35, pp. 2733-2779
Cosyns, B., Plein, S., Nihoyanopoulos, P., Smiseth, O., Achenbach, S., Andrade, M.J., Pepi, M., Lancellotti, P., European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease (2015) Eur Heart J Cardiovasc Imaging, 16, pp. 12-31
Caforio, A.L.P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S.B., Fu, M., Elliott, P.M., Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases (2013) Eur Heart J, 34, pp. 2636-2648
Gonzalez, J.A., Kramer, C.M., Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance (2015) Curr Heart Fail Rep, 12, pp. 276-283
Peix, A., Mesquita, C.T., Paez, D., Pereira, C.C., Felix, R., Gutierrez, C., Jaimovich, R., Garcia, E.V., Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA) (2014) Nucl Med Commun, 35, pp. 818-823
Cooper, L.T., Baughman, K.L., Feldman, A.M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G.N., Virmani, R., The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology (2007) Eur Heart J, 28, pp. 3076-3093
Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., Helio, T., Tavazzi, L., Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases (2010) Eur Heart J, 31, pp. 2715-2728
Lang, R.M., Badano, L.P., Tsang, W., Adams, D.H., Agricola, E., Buck, T., Faletra, F.F., Zoghbi, W.A., EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography (2012) J Am Soc Echocardiogr, 25, pp. 3-46
Rudski, L.G., Lai, W.W., Afilalo, J., Hua, L., Handschumacher, M.D., Chandrasekaran, K., Solomon, S.D., Schiller, N.B., Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography (2010) J Am Soc Echocardiogr, 23, pp. 685-713
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Hoeper, M., 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension (2015) Eur Heart J, 37
Smith, B.C.F., Dobson, G., Dawson, D., Charalampopoulos, A., Grapsa, J., Nihoyannopoulos, P., Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension (2014) J Am Coll Cardiol, 64, pp. 41-51
Sicari, R., Nihoyannopoulos, P., Evangelista, A., Kasprzak, J., Lancellotti, P., Poldermans, D., Voigt, J.U., Zamorano, J.L., Stress Echocardiography Expert Consensus Statement—Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC) (2009) Eur Heart J, 30, pp. 278-289
Garnier, F., Eicher, J.-C., Jazayeri, S., Bertaux, G., Bouchot, O., Aho, L.-S., Wolf, J.-E., Laurent, G., Usefulness and limitations of contractile reserve evaluation in patients with low-flow, low-gradient aortic stenosis eligible for cardiac resynchronization therapy (2014) Eur J Heart Fail, 16, pp. 648-654
Hundley, W.G., Bluemke, D.A., Finn, J.P., Flamm, S.D., Fogel, M.A., Friedrich, M.G., Ho, V.B., Wesley, D.J., ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the american college of cardiology foundation task force on expert consensus documents (2010) Circulation, 121, pp. 2462-2508
Kilner, P.J., Geva, T., Kaemmerer, H., Trindade, P.T., Schwitter, J., Webb, G.D., Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology (2010) Eur Heart J, 31, pp. 794-805
Moon, J.C., Messroghli, D.R., Kellman, P., Piechnik, S.K., Robson, M.D., Ugander, M., Gatehouse, P.D., Schelbert, E.B., Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement (2013) J Cardiovasc Magn Reson, 15, p. 92
Yoshida, A., Ishibashi-Ueda, H., Yamada, N., Kanzaki, H., Hasegawa, T., Takahama, H., Amaki, M., Kitakaze, M., Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure (2013) Eur J Heart Fail, 15, pp. 166-175
Bonow, R.O., Castelvecchio, S., Panza, J.A., Berman, D.S., Velazquez, E.J., Michler, R.E., She, L., Menicanti, L., Severity of remodeling, myocardial viability, and survival in ischemic LV dysfunction after surgical revascularization (2015) JACC Cardiovasc Imaging, 8, pp. 1121-1129
McDiarmid, A.K., Loh, H., Nikitin, N., Cleland, J.G., Ball, S.G., Greenwood, J.P., Plein, S., Sparrow, P., Predictive power of late gadolinium enhancement for myocardial recovery in chronic ischaemic heart failure: a HEART sub-study (2014) ESC Heart Fail, 1, pp. 146-153
Cleland, J.G.F., Calvert, M., Freemantle, N., Arrow, Y., Ball, S.G., Bonser, R.S., Chattopadhyay, S., Senior, R., The heart failure revascularisation trial (HEART) (2011) Eur J Heart Fail, 13, pp. 227-233
Haneder, S., Kucharczyk, W., Schoenberg, S.O., Michaely, H.J., Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis (2015) Top Magn Reson Imaging, 24, pp. 57-65
Beller, G.A., Heede, R.C., SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability (2011) J Cardiovasc Transl Res, 4, pp. 416-424
González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., de Haro-Del Moral, F.J., Cobo-Marcos, M., Robles, C., Bornstein, B., Garcia-Pavia, P., Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction (2015) Eur Heart J, 36, pp. 2585-2594
Beanlands, R.S.B., Nichol, G., Huszti, E., Humen, D., Racine, N., Freeman, M., Gulenchyn, K.Y., Iwanochko, R.M., F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2) (2007) J Am Coll Cardiol, 50, pp. 2002-2012
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Wijns, W., 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) (2014) Eur Heart J, 35, pp. 2541-2619
Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Yildirir, A., 2013 ESC guidelines on the management of stable coronary artery disease (2013) Eur Heart J, 34, pp. 2949-3003
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J.J., Windecker, S., 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (2015) Eur Heart J
Jolicœur, E.M., Dunning, A., Castelvecchio, S., Dabrowski, R., Waclawiw, M.A., Petrie, M.C., Stewart, R., Cleland, J.G.F., Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH (2015) J Am Coll Cardiol, 66, pp. 2092-2100
Allman, K.C., Shaw, L.J., Hachamovitch, R., Udelson, J.E., Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis (2002) J Am Coll Cardiol, 39, pp. 1151-1158
Ling, L.F., Marwick, T.H., Flores, D.R., Jaber, W.A., Brunken, R.C., Cerqueira, M.D., Hachamovitch, R., Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction inducible ischemia versus hibernating myocardium (2013) Circ Cardiovasc Imaging, 6, pp. 363-372
Bonow, R.O., Maurer, G., Lee, K.L., Holly, T.A., Binkley, P.F., Desvigne-Nickens, P., Drozdz, J., Panza, J.A., Myocardial viability and survival in ischemic left ventricular dysfunction (2011) N Engl J Med, 364, pp. 1617-1625
Corrà, U., Piepoli, M.F., Adamopoulos, S., Agostoni, P., Coats, A.J.S., Conraads, V., Lambrinou, E., Ponikowski, P.P., Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC (2014) Eur J Heart Fail, 16, pp. 929-941
Piepoli, M.F., Conraads, V., Corrà, U., Dickstein, K., Francis, D.P., Jaarsma, T., McMurray, J., Ponikowski, P.P., Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation (2011) Eur J Heart Fail, 13, pp. 347-357
Volpicelli, G., Elbarbary, M., Blaivas, M., Lichtenstein, D.A., Mathis, G., Kirkpatrick, A.W., Melniker, L., Petrovic, T., International evidence-based recommendations for point-of-care lung ultrasound (2012) Intensive Care Med, 38, pp. 577-591
Roma-Rodrigues, C., Fernandes, A.R., Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy (2014) Appl Clin Genet, 7, pp. 195-208
McNally, E.M., Golbus, J.R., Puckelwartz, M.J., Genetic mutations and mechanisms in dilated cardiomyopathy (2013) J Clin Invest, 123, pp. 19-26
Priori, S.G., Wilde, A.A., Horie, M., Cho, Y., Behr, E.R., Berul, C., Blom, N., Tracy, C., HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013 (2013) Heart Rhythm, 10, pp. 1932-1963
Arbustini, E., Narula, N., Tavazzi, L., Serio, A., Grasso, M., Favalli, V., Bellazzi, R., Narula, J., The MOGE(S) classification of cardiomyopathy for clinicians (2014) J Am Coll Cardiol, 64, pp. 304-318
Kostis, J.B., Davis, B.R., Cutler, J., Grimm, R.H., Berge, K.G., Cohen, J.D., Lacy, C.R., Applegate, W.B., Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension (1997) JAMA, 278, pp. 212-216
Beckett, N.S., Peters, R., Fletcher, A.E., Staessen, J.A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Bulpitt, C.J., Treatment of hypertension in patients 80 years of age or older (2008) N Engl J Med, 358, pp. 1887-1898
Sciarretta, S., Palano, F., Tocci, G., Baldini, R., Volpe, M., Antihypertensive treatment and development of heart failure in hypertension (2011) Arch Intern Med, 171, pp. 384-394
Wright, J.T., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., Reboussin, D.M., Ambrosius, W.T., A randomized trial of intensive versus standard blood-pressure control (2015) N Engl J Med, 373, pp. 2103-2116
Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Inzucchi, S.E., Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes (2015) N Engl J Med, 373, pp. 2117-2128
Suskin, N., Sheth, T., Negassa, A., Yusuf, S., Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction (2001) J Am Coll Cardiol, 37, pp. 1677-1682
Dorans, K.S., Mostofsky, E., Levitan, E.B., Håkansson, N., Wolk, A., Mittleman, M.A., Alcohol and incident heart failure among middle-aged and elderly men: the cohort of Swedish men (2015) Circ Heart Fail, 8, pp. 422-427
Goncalves, A., Claggett, B., Jhund, P.S., Rosamond, W., Deswal, A., Aguilar, D., Shah, A.M., Solomon, S.D., Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study (2015) Eur Heart J, 36, pp. 939-945
Larsson, S.C., Orsini, N., Wolk, A., Alcohol consumption and risk of heart failure: a dose-response meta-analysis of prospective studies (2015) Eur J Heart Fail, 17, pp. 367-373
Pandey, A., Garg, S., Khunger, M., Darden, D., Ayers, C., Kumbhani, D.J., Mayo, H.G., Berry, J.D., Dose-response relationship between physical activity and risk of heart failure: a meta-analysis (2015) Circulation, 132, pp. 1786-1794
Ledwidge, M., Gallagher, J., Conlon, C., Tallon, E., O'Connell, E., Dawkins, I., Watson, C., McDonald, K., Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial (2013) JAMA, 310, pp. 66-74
Scirica, B.M., Morrow, D.A., Cannon, C.P., Ray, K.K., Sabatine, M.S., Jarolim, P., Shui, A., Braunwald, E., Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study (2006) J Am Coll Cardiol, 47, pp. 2326-2331
Afilalo, J., Majdan, A.A., Eisenberg, M.J., Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials (2007) Heart, 93, pp. 914-921
Kjekshus, J., Pedersen, T.R., Olsson, A.G., Faergeman, O., Pyörälä, K., The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease (1997) J Card Fail, 3, pp. 249-254
Protection, H., Collaborative, S., Emberson, J.R., Ng, L.L., Armitage, J., Bowman, L., Parish, S., Collins, R., N-terminal pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF Heart Protection Study (2007) J Am Coll Cardiol, 49, pp. 311-319
Kenchaiah, S., Evans, J.C., Levy, D., Wilson, P.W.F., Benjamin, E.J., Larson, M.G., Kannel, W.B., Vasan, R.S., Obesity and the risk of heart failure (2002) N Engl J Med, 347, pp. 305-313
Dagenais, G.R., Pogue, J., Fox, K., Simoons, M.L., Yusuf, S., Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials (2006) Lancet, 368, pp. 581-588
Huelsmann, M., Neuhold, S., Resl, M., Strunk, G., Brath, H., Francesconi, C., Adlbrecht, C., Clodi, M., PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial (2013) J Am Coll Cardiol, 62, pp. 1365-1372
Jong, P., Yusuf, S., Rousseau, M.F., Ahn, S.A., Bangdiwala, S.I., Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study (2003) Lancet, 361, pp. 1843-1848
Pfeffer, M.A., Braunwald, E., Moyé, L.A., Basta, L., Brown, E.J., Cuddy, T.E., Davis, B.R., Hawkins, C.M., Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction (1992) N Engl J Med, 327, pp. 669-677
Dargie, H.J., Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial (2001) Lancet, 357, pp. 1385-1390
Montalescot, G., Pitt, B., Lopez de Sa, E., Hamm, C.W., Flather, M., Verheugt, F., Shi, H., Smith, D., Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study (2014) Eur Heart J, 35, pp. 2295-2302
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Gatlin, M., Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction (2003) N Engl J Med, 348, pp. 1309-1321
Moss, A.J., Zareba, W., Hall, W.J., Klein, H., Wilber, D.J., Cannom, D.S., Daubert, J.P., Andrews, M.L., Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction (2002) N Engl J Med, 346, pp. 877-883
Beckett, N.S., Peters, R., Fletcher, A.E., Staessen, J.A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Bulpitt, C.J., Treatment of hypertension in patients 80 years of age or older (2008) N Engl J Med, 358, pp. 1887-1898
Sciarretta, S., Palano, F., Tocci, G., Baldini, R., Volpe, M., Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk (2011) Arch Intern Med, 171, pp. 384-394
Preiss, D., Campbell, R.T., Murray, H.M., Ford, I., Packard, C.J., Sattar, N., Rahimi, K., McMurray, J.J., The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials (2015) Eur Heart J, 36, pp. 1536-1546
Udell, J.A., Cavender, M.A., Bhatt, D.L., Chatterjee, S., Farkouh, M.E., Scirica, B.M., Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials (2015) Lancet Diabetes Endocrinol, 3, pp. 356-366
Padwal, R., McAlister, F.A., McMurray, J.J.V., Cowie, M.R., Rich, M., Pocock, S., Swedberg, K., Bayes-Genis, A., The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data (2014) Int J Obes, 38, pp. 1110-1114
Held, C., Gerstein, H.C., Yusuf, S., Zhao, F., Hilbrich, L., Anderson, C., Sleight, P., Teo, K., Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk (2007) Circulation, 115, pp. 1371-1375
Desai, A.S., Fang, J.C., Maisel, W.H., Baughman, K.L., Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials (2004) JAMA, 292, pp. 2874-2879
Kadish, A., Dyer, A., Daubert, J.P., Quigg, R., Estes, N.A.M., Anderson, K.P., Calkins, H., Levine, J.H., Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy (2004) N Engl J Med, 350, pp. 2151-2158
Hohnloser, S.H., Kuck, K.H., Dorian, P., Roberts, R.S., Hampton, J.R., Hatala, R., Fain, E., Connolly, S.J., Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction (2004) N Engl J Med, 351, pp. 2481-2488
Stewart, S., Jenkins, A., Buchan, S., McGuire, A., Capewell, S., McMurray, J.J.J.V., The current cost of heart failure to the National Health Service in the UK (2002) Eur J Heart Fail, 4, pp. 361-371
Gheorghiade, M., Shah, A.N., Vaduganathan, M., Butler, J., Bonow, R.O., Rosano, G.M.C., Taylor, S., Fonarow, G.C., Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics’, clinicians’, industry's, regulators’, and payers’ perspectives (2013) Heart Fail Clin, 9, pp. 285–290, v–vi
Ambrosy, A.P., Fonarow, G.C., Butler, J., Chioncel, O., Greene, S.J., Vaduganathan, M., Nodari, S., Gheorghiade, M., The global health and economic burden of hospitalizations for heart failure (2014) J Am Coll Cardiol, 63, pp. 1123-1133
McMurray, J.J., Packer, M., Desai, A.S., Gong, J., Lefkowitz, M.P., Rizkala, A.R., Rouleau, J.L., Zile, M.R., Angiotensin-neprilysin inhibition versus enalapril in heart failure (2014) N Engl J Med, 371, pp. 993-1004
Garg, R., Yusuf, S., Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure (1995) JAMA, 273, pp. 1450-1456
Packer, M., Poole-Wilson, P.A., Armstrong, P.W., Cleland, J.G.F., Horowitz, J.D., Massie, B.M., Ryden, L., Uretsky, B.F., Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure (1999) Circulation, 100, pp. 2312-2318
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure (1991) N Engl J Med, 325, pp. 293-302
Maggioni, A.P., Anker, S.D., Dahlström, U., Filippatos, G., Ponikowski, P., Zannad, F., Amir, O., Tavazzi, L., Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry (2013) Eur J Heart Fail, 15, pp. 1173-1184
Hjalmarson, A., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., Deedwania, P., MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive Heart Failure (MERIT-HF) (2000) JAMA, 283, pp. 1295-1302
Packer, M., Coats, A.J., Fowler, M.B., Katus, H.A., Krum, H., Mohacsi, P., Rouleau, J.L., DeMets, D.L., Effect of carvedilol on survival in severe chronic heart failure (2001) N Engl J Med, 344, pp. 1651-1658
Packer, M., Bristow, M.R., Cohn, J.N., Colucci, W.S., Fowler, M.B., Gilbert, E.M., Shusterman, N.H., The effect of carvedilol on morbidity and mortality in patients with chronic heart failure (1996) N Engl J Med, 334, pp. 1349-1355
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (1999) Lancet, 353, pp. 2001-2007
Packer, M., Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study (2002) Circulation, 106, pp. 2194-2199
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial (1999) Lancet, 353, pp. 9-13
Flather, M.D., Shibata, M.C., Coats, A.J.S., Van Veldhuisen, D.J., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Poole-Wilson, P.A., Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) (2005) Eur Heart J, 26, pp. 215-225
Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J., Wittes, J., The effect of spironolactone on morbidity and mortality in patients with severe heart failure (1999) N Engl J Med, 341, pp. 709-717
Zannad, F., McMurray, J.J.V., Krum, H., Van Veldhuisen, D.J., Swedberg, K., Shi, H., Vincent, J., Pitt, B., Eplerenone in patients with systolic heart failure and mild symptoms (2011) N Engl J Med, 364, pp. 11-21
Willenheimer, R., van Veldhuisen, D.J., Silke, B., Erdmann, E., Follath, F., Krum, H., Ponikowski, P., Lechat, P., Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III (2005) Circulation, 112, pp. 2426-2435
Kotecha, D., Holmes, J., Krum, H., Altman, D.G., Manzano, L., Cleland, J.G.F., Lip, G.Y.H., Flather, M.D., Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (2014) Lancet, 384, pp. 2235-2243
Faris, R.F., Flather, M., Purcell, H., Poole-Wilson, P.A., Coats, A.J., Diuretics for heart failure (2012) Cochrane Database Syst Rev, 2, p. CD003838
Faris, R., Flather, M., Purcell, H., Henein, M., Poole-Wilson, P., Coats, A., Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials (2002) Int J Cardiol, 82, pp. 149-158
Swedberg, K., Komajda, M., Böhm, M., Borer, J.S., Ford, I., Dubost-Brama, A., Lerebours, G., Tavazzi, L., Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study (2010) Lancet, 376, pp. 875-885
Swedberg, K., Komajda, M., Böhm, M., Borer, J., Robertson, M., Tavazzi, L., Ford, I., Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study (2012) J Am Coll Cardiol, 59, pp. 1938-1945
Granger, C.B., McMurray, J.J.V., Yusuf, S., Held, P., Michelson, E.L., Olofsson, B., Ostergren, J., Swedberg, K., Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial (2003) Lancet, 362, pp. 772-776
Taylor, A.L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Cohn, J.N., Combination of isosorbide dinitrate and hydralazine in blacks with heart failure (2004) N Engl J Med, 351, pp. 2049-2057
Cohn, J.N., Archibald, D.G., Ziesche, S., Franciosa, J.A., Harston, W.E., Tristani, F.E., Dunkman, W.B., Baker, B., Effect of vasodilator therapy on mortality in chronic congestive heart failure (1986) N Engl J Med, 314, pp. 1547-1552
The effect of digoxin on mortality and morbidity in patients with heart failure (1997) N Engl J Med, 336, pp. 525-533
Tavazzi, L., Maggioni, A.P., Marchioli, R., Barlera, S., Franzosi, M.G., Latini, R., Lucci, D., Tognoni, G., Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial (2008) Lancet, 372, pp. 1223-1230
King, J.B., Bress, A.P., Reese, A.D., Munger, M.A., Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review (2015) Pharmacother J Hum Pharmacol Drug Ther, 35, pp. 823-837
Mangiafico, S., Costello-Boerrigter, L.C., Andersen, I.A., Cataliotti, A., Burnett, J.C., Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics (2013) Eur Heart J, 34, pp. 886-893
Vodovar, N., Paquet, C., Mebazaa, A., Launay, J.-M., Hugon, J., Cohen-Solal, A., Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split (2015) Eur Heart J, 36, pp. 902-905
Yasojima, K., McGeer, E.G., McGeer, P.L., Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain (2001) Brain Res, 919, pp. 115-121
Vepsalainen, S., Helisalmi, S., Mannermaa, A., Pirttila, T., Soininen, H., Hiltunen, M., Vepsäläinen, S., Hiltunen, M., Combined risk effects of IDE and NEP gene variants on Alzheimer disease (2009) J Neurol Neurosurg Psychiatry, 80, pp. 1268-1270
Langenickel, T.H., Tsubouchi, C., Ayalasomayajula, S., Pal, P., Valentin, M.-A., Hinder, M., Jhee, S., Rajman, I., The effect of LCZ696 on amyloid-β concentrations in cerebrospinal fluid in healthy subjects Br J Clin Pharmacol, , doi:10.1111/bcp.12861, 2015 Dec 12., [Epub ahead of print]
Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J.R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Tavazzi, L., Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study (2013) Clin Res Cardiol, 102, pp. 11-22
Cohn, J.N., Tognoni, G., A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure (2001) N Engl J Med, 345, pp. 1667-1675
Ouyang, A.-J., Lv, Y.-N., Zhong, H.-L., Wen, J.-H., Wei, X.-H., Peng, H.-W., Zhou, J., Liu, L.-L., Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation (2015) Am J Cardiol, 115, pp. 901-906
Vamos, M., Erath, J.W., Hohnloser, S.H., Digoxin-associated mortality: a systematic review and meta-analysis of the literature (2015) Eur Heart J, 36, pp. 1831-1838
Ziff, O.J., Lane, D.A., Samra, M., Griffith, M., Kirchhof, P., Lip, G.Y.H., Steeds, R.P., Kotecha, D., Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data (2015) BMJ, 351, p. h4451
Van Gelder, I.C., Groenveld, H.F., Crijns, H.J.G.M., Tuininga, Y.S., Tijssen, J.G.P., Alings, A.M., Hillege, H.L., Van den Berg, M.P., Lenient versus strict rate control in patients with atrial fibrillation (2010) N Engl J Med, 362, pp. 1363-1373
Bavishi, C., Khan, A.R., Ather, S., Digoxin in patients with atrial fibrillation and heart failure: a meta-analysis (2015) Int J Cardiol, 188, pp. 99-101
Freeman, J.V., Reynolds, K., Fang, M., Udaltsova, N., Steimle, A., Pomernacki, N.K., Borowsky, L.H., Go, A.S., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN Study (2015) Circ Arrhythmia Electrophysiol, 8, pp. 49-58
Washam, J.B., Stevens, S.R., Lokhnygina, Y., Halperin, J.L., Breithardt, G., Singer, D.E., Mahaffey, K.W., Patel, M.R., Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) (2015) Lancet, 385, pp. 2363-2370
Mulder, B.A., Van Veldhuisen, D.J., Crijns, H.J.G.M., Tijssen, J.G.P., Hillege, H.L., Alings, M., Rienstra, M., Van Gelder, I.C., Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study (2013) Eur J Heart Fail, 15, pp. 1311-1318
Lucas, M., Kimmig, M., Karalis, G., Do omega-3 polyunsaturated fatty acids prevent cardiovascular disease? A review of the randomized clinical trials (2013) Lipid Insights, 6, pp. 13-20
Reiner, Z., Catapano, A.L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Zamorano, J.L., ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) (2011) Eur Heart J, 32, pp. 1769-1818. , Reviewers D
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J.G.F., Cornel, J.H., Dunselman, P., Wikstrand, J., Rosuvastatin in older patients with systolic heart failure (2007) N Engl J Med, 357, pp. 2248-2261
Homma, S., Thompson, J.L.P., Pullicino, P.M., Levin, B., Freudenberger, R.S., Teerlink, J.R., Ammon, S.E., Investigators, W., Warfarin and aspirin in patients with heart failure and sinus rhythm (2012) N Engl J Med, 366, pp. 1859-1869
Lip, G.Y.H., Ponikowski, P., Andreotti, F., Anker, S.D., Filippatos, G., Homma, S., Morais, J., Lane, D.A., Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (2012) Eur J Heart Fail, 14, pp. 681-695
Gheorghiade, M., Böhm, M., Greene, S.J., Fonarow, G.C., Lewis, E.F., Zannad, F., Solomon, S.D., Maggioni, A.P., Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial (2013) JAMA, 309, pp. 1125-1135
Hernandez, A.V., Usmani, A., Rajamanickam, A., Moheet, A., Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials (2011) Am J Cardiovasc Drugs, 11, pp. 115-128
Komajda, M., McMurray, J.J.V., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Pocock, S.J., Curtis, P.S., Home, P.D., Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial (2010) Eur Heart J, 31, pp. 824-831
Mamdani, M., Juurlink, D.N., Lee, D.S., Rochon, P.A., Kopp, A., Naglie, G., Austin, P.C., Stukel, T.A., Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study (2004) Lancet, 363, pp. 1751-1756
Huerta, C., Varas-Lorenzo, C., Castellsague, J., García Rodríguez, L.A., Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population (2006) Heart, 92, pp. 1610-1615
Scott, P.A., Kingsley, G.H., Scott, D.L., Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials (2008) Eur J Heart Fail, 10, pp. 1102-1107
Goldstein, R.E., Boccuzzi, S.J., Cruess, D., Nattel, S., Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee and the Multicenter Diltiazem Postinfarction Research Group (1991) Circulation, 83, pp. 52-60
Packer, M., O'Connor, C.M., Ghali, J.K., Pressler, M.L., Carson, P.E., Belkin, R.N., Miller, A.B., DeMets, D.L., Effect of amlodipine on morbidity and mortality in severe chronic heart failure (1996) N Engl J Med, 335, pp. 1107-1114
Cohn, J.N., Ziesche, S., Smith, R., Anand, I., Dunkman, W.B., Loeb, H., Cintron, G., Loss, L., Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group (1997) Circulation, 96, pp. 856-863
Abraham, W.T., Zile, M.R., Weaver, F.A., Butter, C., Ducharme, A., Halbach, M., Klug, D., Little, W.C., Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction (2015) JACC Heart Fail, 3, pp. 487-496
Zannad, F., De Ferrari, G.M., Tuinenburg, A.E., Wright, D., Brugada, J., Butter, C., Klein, H., Ruble, S.B., Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial (2015) Eur Heart J, 36, pp. 425-433
Ponikowski, P., Javaheri, S., Michalkiewicz, D., Bart, B.A., Czarnecka, D., Jastrzebski, M., Kusiak, A., Abraham, W.T., Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure (2012) Eur Heart J, 33, pp. 889-894
Abraham, W.T., Jagielski, D., Oldenburg, O., Augostini, R., Krueger, S., Kolodziej, A., Gutleben, K.-J., Ponikowski, P., Phrenic nerve stimulation for the treatment of central sleep apnea (2015) JACC Heart Fail, 3, pp. 360-369
Kadish, A., Nademanee, K., Volosin, K., Krueger, S., Neelagaru, S., Raval, N., Obel, O., Abraham, W.T., A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure (2011) Am Heart J, 161, pp. 329–337.e2
Borggrefe, M.M., Lawo, T., Butter, C., Schmidinger, H., Lunati, M., Pieske, B., Misier, A.R., Hindricks, G., Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure (2008) Eur Heart J, 29, pp. 1019-1028
Wyse, D.G., Friedman, P.L., Epstein, A.E., A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) N Engl J Med, 337, pp. 1576-1583
Connolly, S.J., Hallstrom, A.P., Cappato, R., Schron, E.B., Kuck, K.H., Zipes, D.P., Greene, H.L., Roberts, R.S., Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study (2000) Eur Heart J, 21, pp. 2071-2078
Connolly, S.J., Gent, M., Roberts, R.S., Dorian, P., Roy, D., Sheldon, R.S., Mitchell, L.B., O'Brien, B., Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone (2000) Circulation, 101, pp. 1297-1302
Kuck, K.H., Cappato, R., Siebels, J., Rüppel, R., Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) (2000) Circulation, 102, pp. 748-754
Bardy, G.H., Lee, K.L., Mark, D.B., Poole, J.E., Packer, D.L., Boineau, R., Domanski, M., Ip, J.H., Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure (2005) N Engl J Med, 352, pp. 225-237
Steinbeck, G., Andresen, D., Seidl, K., Brachmann, J., Hoffmann, E., Wojciechowski, D., Kornacewicz-Jach, Z., Senges, J., Defibrillator implantation early after myocardial infarction (2009) N Engl J Med, 361, pp. 1427-1436
Sanders, G.D., Hlatky, M.A., Owens, D.K., Cost-effectiveness of implantable cardioverter-defibrillators (2005) N Engl J Med, 353, pp. 1471-1480
Steinberg, B.A., Al-Khatib, S.M., Edwards, R., Han, J., Bardy, G.H., Bigger, J.T., Buxton, A.E., Sanders, G.D., Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials (2014) JACC Heart Fail, 2, pp. 623-629
Raphael, C.E., Finegold, J.A., Barron, A.J., Whinnett, Z.I., Mayet, J., Linde, C., Cleland, J.G.F., Francis, D.P., The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most (2015) Eur Heart J, 36, pp. 1676-1688
Miller, R.J.H., Howlett, J.G., Exner, D.V., Campbell, P.M., Grant, A.D.M., Wilton, S.B., Baseline functional class and therapeutic efficacy of common heart failure interventions: a systematic review and meta-analysis (2015) Can J Cardiol, 31, pp. 792-799
Hess, P.L., Al-Khatib, S.M., Han, J.Y., Edwards, R., Bardy, G.H., Bigger, J.T., Buxton, A., Sanders, G., Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials (2015) Circ Cardiovasc Qual Outcomes, 8, pp. 179-186
Merchant, F.M., Jones, P., Wehrenberg, S., Lloyd, M.S., Saxon, L.A., Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life (2014) J Am Heart Assoc, 3
Yap, S.-C., Schaer, B.A., Bhagwandien, R.E., Kuhne, M., Dabiri Abkenari, L., Osswald, S., Szili-Torok, T., Theuns, D.A., Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy (2014) Heart, 100, pp. 1188-1192
Kini, V., Soufi, M.K., Deo, R., Epstein, A.E., Bala, R., Riley, M., Groeneveld, P.W., Dixit, S., Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met (2014) J Am Coll Cardiol, 63, pp. 2388-2394
Erkapic, D., Sperzel, J., Stiller, S., Meltendorf, U., Mermi, J., Wegscheider, K., Hügl, B., Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: Results of the INcidence free SUrvival after ICD REplacement (INSURE) trial—a prospective multicentre study (2013) Eur Heart J, 34, pp. 130-137
Alsheikh-Ali, A.A., Homer, M., Maddukuri, P.V., Kalsmith, B., Estes, N.A.M., Link, M.S., Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy (2008) J Cardiovasc Electrophysiol, 19, pp. 784-789
Opreanu, M., Wan, C., Singh, V., Salehi, N., Ahmad, J., Szymkiewicz, S.J., Thakur, R.K., Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: a national database analysis (2015) J Heart Lung Transplant, 34, pp. 1305-1309
Zishiri, E.T., Williams, S., Cronin, E.M., Blackstone, E.H., Ellis, S.G., Roselli, E.E., Smedira, N.G., Chung, M.K., Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator (2013) Circ Arrhythm Electrophysiol, 6, pp. 117-128
Chung, M.K., Szymkiewicz, S.J., Shao, M., Zishiri, E., Niebauer, M.J., Lindsay, B.D., Tchou, P.J., Aggregate national experience with the wearable cardioverter-defibrillator (2010) J Am Coll Cardiol, 56, pp. 194-203
Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators (1997) Lancet, 350, pp. 1417-1424
Andrey, J.L., Gomez-Soto, F.M., Romero, S.P., Escobar, M.A., García-Egido, A.A., Garcia-Arjona, R., Gomez, F., Mortality of newly diagnosed heart failure treated with amiodarone: a propensity-matched study (2011) Int J Cardiol, 151, pp. 175-181
Torp-Pedersen, C., Metra, M., Spark, P., Lukas, M.A., Moullet, C., Scherhag, A., Komajda, M., Poole-Wilson, P.A., The safety of amiodarone in patients with heart failure (2007) J Card Fail, 13, pp. 340-345
Piepoli, M., Villani, G.Q., Ponikowski, P., Wright, A., Flather, M.D., Coats, A.J., Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure (1998) Int J Cardiol, 66, pp. 1-10
Chatterjee, S., Ghosh, J., Lichstein, E., Aikat, S., Mukherjee, D., Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure (2012) Am J Cardiol, 110, pp. 607-613
Køber, L., Torp-Pedersen, C., McMurray, J.J.V., Gøtzsche, O., Lévy, S., Crijns, H., Amlie, J., Carlsen, J., Increased mortality after dronedarone therapy for severe heart failure (2008) N Engl J Med, 358, pp. 2678-2687
Echt, D.S., Liebson, P.R., Mitchell, L.B., Peters, R.W., Obias-Manno, D., Barker, A.H., Arensberg, D., Richardson, D.W., Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial (1991) N Engl J Med, 324, pp. 781-788
Theuns, D.A.M.J., Smith, T., Hunink, M.G.M., Bardy, G.H., Jordaens, L., Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis (2010) Europace, 12, pp. 1564-1570
Cook, N.R., Ridker, P.M., Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures (2009) Ann Intern Med, 150, pp. 795-802
Moss, A.J., Hall, W.J., Cannom, D.S., Daubert, J.P., Higgins, S.L., Klein, H., Levine, J.H., Heo, M., Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators (1996) N Engl J Med, 335, pp. 1933-1940
Moss, A.J., Schuger, C., Beck, C.A., Brown, M.W., Cannom, D.S., Daubert, J.P., Estes, N.A.M., Zareba, W., Reduction in inappropriate therapy and mortality through ICD programming (2012) N Engl J Med, 367, pp. 2275-2283
Gasparini, M., Proclemer, A., Klersy, C., Kloppe, A., Lunati, M., Ferrer, J.B.M., Hersi, A., Arenal, A., Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial (2013) JAMA, 309, pp. 1903-1911
